Americas Antibody Congress 2016

 

Innovate.

Collaborate.

 Commercialize.

THE LEADING CONFERENCE ON ANTI-MICROBIAL RESISTANCE 
 

Americas Antibody Congress 2017

DOWNLOAD THE PROSPECTUS

The prospectus for this year's event is now available! Learn more about the leading conference on antimicrobial resistance!

 

DOWNLOAD PROSPECTUS

SIGN UP FOR EVENT UPDATES

" Excellent networking opportunities "

-Infection Control Specialist, Howard University Hospital

 

What's new in 2017 
 

 

DIAGNOSTICS STREAM

 The focus is shifting toward increasing speed and accuracy of patient diagnosis as a manner of alleviating the general need for antibiotics. With this shift in focus comes a need we've recognized in this space to provide a platform for leaders in the diagnostics and healthcare industries to discuss developments and improvements to help minimize the need for antibiotics and achieve effective diagnosis sooner.

 

STEWARDSHIP STREAM

Stewardship is the effort to prevent this improper use of drugs, aiming for optimizing everything prescription to duration of treatment to administration of treatment. Much like diagnostics, stewardship provides a potential solution to this growing problem alternative to new antibiotic development.

INNOVATION SHOWCASE

At Innovation Showcase, we will provide a platform for innovative solutions to be presented to potential partners and investors in the audience. From biotechs developing non-traditional therapeutics to susceptibility testing platforms, this is the opportunity for your organization to showcase your solution to the AMR community.

 

 

 

 

 

 

DOWNLOAD PROSPECTUS

CONFIRMED SPEAKERS

 

  • Ritu Banerjee at World Anti-Microbial Resistance Congress USA 2017
    Ritu Banerjee
    Associate Professor of Pediatrics
    Vanderbilt Antimicrobial Stewardship Program (VASP)
    Oren Cohen at World Anti-Microbial Resistance Congress USA 2017
    Oren Cohen
    Chief Medical Officer
    Viamet Pharmaceuticals
    Timothy Cooke at World Anti-Microbial Resistance Congress USA 2017
    Timothy Cooke
    Chief Executive Officer
    NovaDigm Therapeutics
  • Ian Critchley at World Anti-Microbial Resistance Congress USA 2017
    Ian Critchley
    Vice President of Clinical Microbiology
    Allergan Pharmaceuticals Inc
    Gregory Daniel at World Anti-Microbial Resistance Congress USA 2017
    Gregory Daniel
    Deputy Director
    Duke University
    Enea Di Domenico at World Anti-Microbial Resistance Congress USA 2017
    Enea Di Domenico
    Clinical Pathology and Microbiology
    Istituti Fisioterapici Ospitalieri
  • Michael Draper at World Anti-Microbial Resistance Congress USA 2017
    Michael Draper
    Senior Director, External Science and Partnering
    Sanofi
    Michael Dudley at World Anti-Microbial Resistance Congress USA 2017
    Michael Dudley
    Senior VP of Research and Development and CSO
    The Medicines Company
    Scott Evans at World Anti-Microbial Resistance Congress USA 2017
    Scott Evans
    Director, Statistical and Data Management Center (SDMC) for the Antibacterial Resistance Leadership Group (ARLG)
    Harvard University
  • Jean-Marc Ghigo at World Anti-Microbial Resistance Congress USA 2017
    Jean-Marc Ghigo
    Head of Genetics of Biofilms Lab
    Institut Pasteur
    Steven Gilman at World Anti-Microbial Resistance Congress USA 2017
    Steven Gilman
    Chairman & CEO
    Contrafect Corporation
    Debra Goff at World Anti-Microbial Resistance Congress USA 2017
    Debra Goff
    Clinical Associate Professor
    The Ohio State University Medical Center
  • Keith Hamilton at World Anti-Microbial Resistance Congress USA 2017
    Keith Hamilton
    Director
    Hospital of the University of Pennsylvania
    Evan Hecker at World Anti-Microbial Resistance Congress USA 2017
    Evan Hecker
    Director of API Development
    Spero Therapeutics LLC
    Elizabeth Hermsen at World Anti-Microbial Resistance Congress USA 2017
    Elizabeth Hermsen
    Head, Global Antimicrobial Stewardship
    Merck & Co., Inc.
  • Lauri Hicks at World Anti-Microbial Resistance Congress USA 2017
    Lauri Hicks
    Medical Epidemiologist
    Centers for Disease Control & Prevention
    Chris Houchens at World Anti-Microbial Resistance Congress USA 2017
    Chris Houchens
    PhD, Branch Chief (Acting), Antibacterials Program
    BARDA
    Romney Humphries at World Anti-Microbial Resistance Congress USA 2017
    Romney Humphries
    Section Chief,Clinical Microbiology
    Ucla Health System University of California Los Angeles
  • Deborah Hung at World Anti-Microbial Resistance Congress USA 2017
    Deborah Hung
    Director of Infectious Disease Program
    Broad Institute of M.I.T. & Harvard
    Peter Jackson at World Anti-Microbial Resistance Congress USA 2017
    Peter Jackson
    Executive Chairman
    The AMR Centre UK
    Lee Jones at World Anti-Microbial Resistance Congress USA 2017
    Lee Jones
    Founder, President and Chief Executive Officer
    Rebiotix, Inc.
  • Adrian Jubb at World Anti-Microbial Resistance Congress USA 2017
    Adrian Jubb
    Vice President and Head of Early Development
    Achaogen
    Jane Knisely at World Anti-Microbial Resistance Congress USA 2017
    Jane Knisely
    Program Officer, Bacteriology and Mycology Branch, NIAID
    NIH - NIAID & University of Kansas
    Sophia Koo at World Anti-Microbial Resistance Congress USA 2017
    Sophia Koo
    Assistant Professor of Medicine
    Harvard Medical School
  • Joseph Larsen at World Anti-Microbial Resistance Congress USA 2017
    Joseph Larsen
    Director (Acting)
    BARDA
    Nicole Mahoney at World Anti-Microbial Resistance Congress USA 2017
    Nicole Mahoney
    Director of Government Affairs and Regulatory Policy
    Merck
    Valerie Oriol Mathieu at World Anti-Microbial Resistance Congress USA 2017
    Valerie Oriol Mathieu
    Global Medical Affairs Lead, Vaccines
    Janssen Vaccines & Prevention
  • Andrew McCandlish at World Anti-Microbial Resistance Congress USA 2017
    Andrew McCandlish
    Director, Corporate Development
    Achaogen
    Clive Meanwell at World Anti-Microbial Resistance Congress USA 2017
    Clive Meanwell
    Chief Executive Officer
    The Medicines Company
    Tyler Merkley at World Anti-Microbial Resistance Congress USA 2017
    Tyler Merkley
    Program Manager
    CARB-X
  • Pierre Meulien at World Anti-Microbial Resistance Congress USA 2017
    Pierre Meulien
    Executive Director of Innovative Medicines Initiative
    Innovative Medicines Initiative
    Catharine Moffitt at World Anti-Microbial Resistance Congress USA 2017
    Catharine Moffitt
    Senior Medical Director
    Aetna
    Gareth Morgan at World Anti-Microbial Resistance Congress USA 2017
    Gareth Morgan
    Senior Portfolio Management Vice President
    Shionogi Inc
  • Jason Newland at World Anti-Microbial Resistance Congress USA 2017
    Jason Newland
    Director
    Washington University in St. Louis
    Jean Patel at World Anti-Microbial Resistance Congress USA 2017
    Jean Patel
    Deputy Director, Office of Antimicrobial Resistance
    Center for Disease Control & Prevention
    David Paterson at World Anti-Microbial Resistance Congress USA 2017
    David Paterson
    Professor Of Medicine
    University Of Queensland Centre For Clinical Research
  • Manos Perros at World Anti-Microbial Resistance Congress USA 2017
    Manos Perros
    President & CEO
    Entasis Therapeutics
    Yannick Pletan at World Anti-Microbial Resistance Congress USA 2017
    Yannick Pletan
    Senior Consultant
    ULTRACE
    Aleks Radovic-Moreno at World Anti-Microbial Resistance Congress USA 2017
    Aleks Radovic-Moreno
    Senior Associate
    PureTech Health
  • Jeffrey Riley at World Anti-Microbial Resistance Congress USA 2017
    Jeffrey Riley
    Chief Executive Officer, Director and President
    Synthetic Biologics
    Ribhi Shawar at World Anti-Microbial Resistance Congress USA 2017
    Ribhi Shawar
    Branch Chief, Division of Microbiology
    CDRH OIR FDA
    Jeff Stein at World Anti-Microbial Resistance Congress USA 2017
    Jeff Stein
    President and Chief Executive Officer
    Cidara Therapeutics
  • Melissa Stundick at World Anti-Microbial Resistance Congress USA 2017
    Melissa Stundick
    Head of Strategic Alliances
    Spero Therapeutics LLC
    Dolca Thomas at World Anti-Microbial Resistance Congress USA 2017
    Dolca Thomas
    Vice President and Head of Translational Medicine for Immunology and Inflammation and Infectious Disease
    Roche
    Vu Truong at World Anti-Microbial Resistance Congress USA 2017
    Vu Truong
    Founder, Chief Executive Officer and Director
    Aridis Pharmaceuticals
  • David Visi at World Anti-Microbial Resistance Congress USA 2017
    David Visi
    Senior Associate, Antibiotic Resistance Project
    The Pew Charitable Trusts
    Bernhardt Zeiher at World Anti-Microbial Resistance Congress USA 2017
    Bernhardt Zeiher
    President, Global Development
    Astellas Pharma Global Development Inc
    Zachary Zimmerman at World Anti-Microbial Resistance Congress USA 2017
    Zachary Zimmerman
    CEO
    Forge Therapeutics

 

DOWNLOAD PROSPECTUS

Find out more about World Anti-Microbial Resistance Congress 2017

 Sponsors

 

Platinum Sponsor

Biofilm Control at World Anti-Microbial Resistance Congress USA 2017

Event Sponsor

 

SPONSOR NOW

PAST ATTENDEES INCLUDE

See who attends World Anti-Microbial Resistance Congress USA

 

FIND OUT MORE

 

" The content was fantastic" "

-- Solutions Manager, Cepheid